Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study
Author(s) -
J. J. Dixon,
Maggi Steele,
Akinwale D Makanjuola
Publication year - 2012
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfs081
Subject(s) - medicine , gentamicin , vancomycin , bacteremia , ciprofloxacin , staphylococcus aureus , incidence (geometry) , antibiotics , enterobacter , microbiology and biotechnology , antibiotic resistance , retrospective cohort study , cohort , pseudomonas aeruginosa , gastroenterology , bacteria , biology , escherichia coli , biochemistry , genetics , physics , optics , gene
Anti-microbial lock solutions (AML), in conjunction with systemic antibiotics, may successfully treat tunnelled haemodialysis catheter-related bloodstream infections (CR-BSI). It is unknown whether AML promote anti-microbial resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom